Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
rejecting would be easier decision than approving. by requesting for further information, probably it s pointing that the authority needing more evidence and data to support the upcoming approval decision. if there is any errors or unsatisfactory evidence, the authority would have rejected the application by now.
latest news on the Taurx drug. UK MHRA require further information. base on last RFI, it took almost 9 months for both sides to prepare data and review and decide. now with this second round of RFI, hopefully it could reduce 50% of the cycle time as now they should have zero into specific areas for further review. 4.5 months from now would be by mod February 2026.
as what you said, as long as the BOD still destroying value by investing more into US, the more depressing Genting would be. and the situation has gone from bad to worst when the BOD did not declare dividend in its history.
that s the current situation now. I was hoping that they would try to take over and control the board by increasing their shareholdings but instead the wife is trying to wind down the whole company and sell the assets.
